Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Return on Equity %

Bristol-Myers Squibb Company Return on Equity % Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Return on Equity % from 2010 to 2020.
  • Bristol-Myers Squibb Company Return on Equity % for the quarter ending June 06, 2020 was -0.65 a 5,095.54% decrease of -32.88 year over year
  • Bristol-Myers Squibb Company Return on Equity % for the last 12 months ending June 06, 2020 was -1.65 a 2,279.86% decrease of -37.70 year over year
  • Bristol-Myers Squibb Company Annual Return on Equity % for 2019 was 10.51 a -262.34% decrease of -27.58 from 2018
  • Bristol-Myers Squibb Company Annual Return on Equity % for 2018 was 38.09 a 81.84% increase of 31.18 from 2017
  • Bristol-Myers Squibb Company Annual Return on Equity % for 2017 was 6.92 a -323.55% decrease of -22.38 from 2016
Other Margins & Efficiency Metrics:
  • Bristol-Myers Squibb Company EBITDA Margin for the quarter ending December 12, 2018 was $32m a 2.83% increase of 1m year over year
  • Bristol-Myers Squibb Company Return on Capital % for the quarter ending December 12, 2018 was 20.85 a 12.59% increase of 2.62 year over year
View Chart On Koyfin

Quarterly BMY Return on Equity % Data

06/2020-0.65
03/2020-6.03
12/2019-12.21
09/201932.23
06/201936.58
03/201946.60
12/201833.23
09/201858.45
06/201812.07
03/201848.32

Annual BMY Return on Equity % Data

201910.51
201838.09
20176.92
201629.29
201511.09
201413.43
201317.87
201216.95
201133.39
201029.67